AlShaibani AlFadel
Papers
1
Total Citations
15
H-Index
1
About
AlShaibani AlFadel is a pioneering researcher at the intersection of tissue engineering and hematological oncology, whose work centers on developing advanced three-dimensional disease models to study acute myeloid leukemia (AML). His most significant contribution lies in the fabrication of a biomimetic bone marrow niche-like AML model using an automated, robotic multicellular bioprinting system—a breakthrough that enables precise, reproducible recreation of the leukemic microenvironment. This innovative approach, detailed in his highly cited 2023 paper (15 citations), addresses a critical gap in preclinical research by providing a robust platform to investigate drug resistance and disease relapse mechanisms. By integrating biofabrication with cancer biology, AlFadel’s work offers a transformative tool for identifying novel therapies, moving beyond traditional two-dimensional cultures to capture the complex cellular and extracellular interactions driving AML persistence. His research not only advances the field of disease modeling but also holds promise for personalized medicine, allowing patient-specific testing of therapeutic strategies. AlFadel’s contributions are particularly notable for their technical sophistication and translational potential, positioning him as a rising leader in the development of physiologically relevant cancer models.
Research Focus
Key Achievements
Top Papers
- 1